ABOUT US

A wholly owned subsidiary of a global pharmaceutical supplier

OUR PRODUCTS

First to market pharmaceutical compounds; unique, therapeutically optimized combinations; value branded equivalents

CONTACT US

Need more information? Would like to provide feedback? Interested in collaboration?
Ajanta Tri-Senza2
Ajanta Alzor HCT Main W
Ajanta Rosucol2
Ajanta Alduet Main W
Ajanta Nebiloc2
Ajanta Carveta Main W
Ajanta Glipten Main W
Ajanta Alzor CCB2 Main W
Ajanta Warik2 Main W
Ajanta Glyzeric Main W
Ajanta Kamagra Main W
Ajanta Tamplus Main W
Ajanta Alzor Plain Main W
Ajanta Kamagra Main W
Ajanta Synactiv2
Ajanta Maxivent2
Ajanta Dimezine222
Ajanta Kamagra Main W
Ajanta Rosugrel2
Ajanta Tri-alzor Main W
Ajanta Kamagra Main W
Ajanta Razine Main W
Ajanta Rosuprin2
Ajanta Asenza Plus2
Ajanta Kamagra Main W
Ajanta Kamagra Main W
Ajanta Kamagra Main W
Ajanta Rosufen2
Ajanta Neurogesic Main W
Ajanta co-altria2
Ajanta Co-Altria Ped2
Ajanta Kamagra Main W
Ajanta Kamagra Main W
Ajanta Atenurix Main W
Ajanta Fenostat2
Ajanta Kamagra Main W
Ajanta Razine Tile WO
Ajanta Alduet Tile WO
Ajanta Dimezine22
Ajanta Fenostat
Ajanta Glyzeric Tile WO
Ajanta Kamagra Tile WO
Ajanta Nebiloc
Ajanta Neurogesic Tile WO
Ajanta Synactiv
Ajanta Synactiv logo tile 2
Ajanta Alzor CCB Logo
Ajanta Nebiloc logo tile
Ajanta Razine Logo
Ajanta Glipten Logo
Ajanta Carveta Logo
  • VIEW ALL
Ajanta Atenurix Main W
Atenurix
Best in Class Anti-hyperuricemic Agent
Ajanta Rosufen2
Rosufen
Ajanta Fenostat2
Fenostat
The Good, The Bad and the Ugly
Ajanta Glyzeric Main W
Glyzeric
Two Great Performers
Ajanta Rosugrel2
Rosugrel
Dual Vascular Protection
Ajanta Razine Main W
Razine
Take control of Angina
Ajanta Neurogesic Main W
Nurogesic B
Dual Acting Relief for Diabetic Neuropathy
Ajanta Glipten Main W
Glipten
Take Control of Type ll Diabetes
Ajanta Asenza Plus2
Asenza Plus
Targt the Defects in Type 2 Diabetes
Ajanta Maxivent2
Maxivent
Helps Patients with COPD Breathe Better
Ajanta Nebiloc2
Nebiloc CCB
Ajanta Alzor HCT Main W
Alzor HCT
Helping More Patients Achieve Target BP
  • VIEW ALL
Ajanta Neurogesic Main W
Nurogesic B
Dual Acting Relief for Diabetic Neuropathy
Ajanta Alzor HCT Main W
Alzor HCT
Helping More Patients Achieve Target BP
Ajanta Alzor Plain Main W
Alzor
Helping More Patients Achieve Target BP
Ajanta Rosuprin2
Rosuprin
Dual Protection
Ajanta Alzor CCB2 Main W
Alzor CCB
Helping More Patients Achieve Target BP
Ajanta Kamagra Main W
Kamagra
Kamagra Inspires Confidence
Ajanta Glipten Main W
Glipten
Take Control of Type ll Diabetes
Ajanta Warik2 Main W
Warik
Warik Saves
Ajanta co-altria2
Co-Altria
A New Improved Way for Allergic Rhinitis
Ajanta Alduet Main W
Alduet
Start Living. A New Improved Way for Allergic Rhinitis
Ajanta Fenostat2
Fenostat
The Good, The Bad and the Ugly
Ajanta Razine Main W
Razine
Take control of Angina
  • VIEW ALL
  • LATEST ARTICLES
07.22.2014
Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
Hyperuricemia is a frequent complication of chronic kidney disease (CKD). Febuxostat is a novel xanthine oxidase inhibitor that is metabolized...

Read more...

07.07.2014
Ajanta Pharma Philippines Inc introduces Glyzeric; the first fixed dose combination containing the gliclazide 80mg and metformin 500mg for the...

Read more...

06.18.2014
Tri-Senza, Fenostat and Dimezine, three new and first to market fixed dose combinations launched. Tri-Senza is a triple combination containing...

Read more...

05.08.2014
Fenostat, containing atorvastatin 10mg and fenofibrate 160mg, helps lower LDL cholesterol and triglycerides while increasing HDL cholesterol.

Read more...

05.05.2014
Dimezine (a fixed dose combination of dimenhydrinate 40mg and cinnarizine 20mg) is the first new treatment option for vertigo in...

Read more...

  • LATEST ARTICLES
07.22.2014
Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
Hyperuricemia is a frequent complication of chronic kidney disease (CKD). Febuxostat is a novel xanthine oxidase inhibitor that is metabolized...

Read more...

07.07.2014
Ajanta Pharma Philippines Inc introduces Glyzeric; the first fixed dose combination containing the gliclazide 80mg and metformin 500mg for the...

Read more...

06.18.2014
Tri-Senza, Fenostat and Dimezine, three new and first to market fixed dose combinations launched. Tri-Senza is a triple combination containing...

Read more...

05.08.2014
Fenostat, containing atorvastatin 10mg and fenofibrate 160mg, helps lower LDL cholesterol and triglycerides while increasing HDL cholesterol.

Read more...

05.05.2014
Dimezine (a fixed dose combination of dimenhydrinate 40mg and cinnarizine 20mg) is the first new treatment option for vertigo in...

Read more...

ABOUT US

A wholly owned subsidiary of a global pharmaceutical supplier

OUR PRODUCTS

First to market pharmaceutical compounds, unique therapeutically optimized combinations, value branded equivalents

CAREERS @ AJANTA

Looking for a challenging and rewarding career?

Apply here

PATIENT RESOURCES

Links to online educational materials